Volitionrx (VNRX) Revenue (2012 - 2025)

Volitionrx (VNRX) reported Revenue of -$3771.0 for Q4 2025, up 89.66% on a YoY basis from -$1988.3 in Q4 2024, and down 100.7% quarter-over-quarter from $538381.0 in Q3 2025.

Volitionrx (VNRX) Revenue (2012 - 2025) Analysis & Trends

Volitionrx has reported Revenue for 8 years, with the latest figure at -$3771.0 in Q4 2025.

  • For the quarter ending Q4 2025, Revenue rose 89.66% year-over-year to -$3771.0; the trailing twelve-month figure through Dec 2025 stood at $1.2 million (up 26.76% YoY), and the FY2025 full-year result was $1.3 million, up 26.98% from the prior year.
  • Revenue for Q4 2025 stood at -$3771.0, down from $538381.0 in the prior quarter.
  • The five-year high for Revenue was $538381.0 in Q3 2025, with the low at -$36481.0 in Q4 2024.
  • Historically, Revenue has averaged $164817.6 across 5 years, with a median of $134761.5 in 2022.
  • Annual changes were most pronounced in 2021 — Revenue jumped 8298.03% — and 2024, when it tumbled 114.95%.
  • Volitionrx's Revenue stood at $14240.0 in 2021, then soared by 740.7% to $119715.0 in 2022, then soared by 103.79% to $243973.0 in 2023, then plunged by 114.95% to -$36481.0 in 2024, then soared by 89.66% to -$3771.0 in 2025.
  • The last three Revenue figures came in at -$3771.0 (Q4 2025), $538381.0 (Q3 2025), and $406688.0 (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 11.16 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 6.02 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 9.02 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 5.20 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 1.65 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 4.57 Bn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 1.19 Bn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 5.13 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 1.59 Bn
10 Volitionrx 53.00 Mn 50.54 Mn -1.01 Mn -3,771.00

Historic Data

Download Data
DateValue
Dec 31, 2025 -3,771.00
Sep 30, 2025 538,381.00
Jun 30, 2025 406,688.00
Mar 31, 2025 246,385.00
Dec 31, 2024 -36,481.00
Sep 30, 2024 406,088.00
Jun 30, 2024 395,797.00
Mar 31, 2024 171,535.00
Dec 31, 2023 243,973.00
Sep 30, 2023 165,211.00
Jun 30, 2023 216,310.00
Mar 31, 2023 149,808.00
Dec 31, 2022 119,715.00
Sep 30, 2022 32,714.00
Jun 30, 2022 39,752.00
Mar 31, 2022 114,211.00
Dec 31, 2021 14,240.00
Sep 30, 2021 25,483.00
Jun 30, 2021 24,782.00
Mar 31, 2021 25,530.00